TW253835B - - Google Patents

Info

Publication number
TW253835B
TW253835B TW082109940A TW82109940A TW253835B TW 253835 B TW253835 B TW 253835B TW 082109940 A TW082109940 A TW 082109940A TW 82109940 A TW82109940 A TW 82109940A TW 253835 B TW253835 B TW 253835B
Authority
TW
Taiwan
Application number
TW082109940A
Other languages
Chinese (zh)
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10725687&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TW253835(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wellcome Found filed Critical Wellcome Found
Application granted granted Critical
Publication of TW253835B publication Critical patent/TW253835B/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/155Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06Antimalarials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/08Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis for Pneumocystis carinii
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TW082109940A 1992-11-26 1993-11-25 TW253835B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929224739A GB9224739D0 (en) 1992-11-26 1992-11-26 Medicaments

Publications (1)

Publication Number Publication Date
TW253835B true TW253835B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1995-08-11

Family

ID=10725687

Family Applications (1)

Application Number Title Priority Date Filing Date
TW082109940A TW253835B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1992-11-26 1993-11-25

Country Status (37)

Country Link
US (3) US5998449A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0670719B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JP3768231B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR100294802B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CN (1) CN1087935C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AP (1) AP517A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE191340T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU685408B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BG (1) BG62595B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA2150234E (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CY (1) CY2193B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CZ (2) CZ289171B6 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE69328307T2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK0670719T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES2145114T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB9224739D0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR3033745T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HU225918B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL107755A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MX (1) MX9307402A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MY (1) MY114241A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO313225B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ257901A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
OA (1) OA10352A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PE (1) PE55694A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PL (1) PL174323B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT670719E (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
RO (1) RO119280B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
RU (1) RU2108092C1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SA (1) SA93140434B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SG (1) SG45387A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SI (1) SI9300614A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SK (1) SK281559B6 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
TW (1) TW253835B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
UA (1) UA45948C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
WO (1) WO1994012164A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA938832B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9224739D0 (en) * 1992-11-26 1993-01-13 Wellcome Found Medicaments
GB9424013D0 (en) * 1994-11-29 1995-01-18 Wellcome Found Medicaments
DE19737463A1 (de) * 1997-08-28 1999-03-04 Hoechst Marion Roussel De Gmbh Verwendung von Inhibitoren des Natrium-Wasserstoff-Austauschers zur Herstellung eines Arzneimittels zur Behandlung von Erkrankungen, die durch Protozoen verursacht werden
GB9822681D0 (en) * 1998-10-16 1998-12-09 Vitabiotics Ltd Method of treatment
MXPA01010125A (es) * 1999-04-09 2002-06-04 Glaxo Group Ltd Combinacion de una preparacion para el tratamiento de la malaria.
US7104076B2 (en) * 2004-06-24 2006-09-12 Carrier Corporation Lubricant return schemes for use in refrigerant cycle
ITMI20070941A1 (it) * 2007-05-09 2008-11-10 Chimico Internazi0Nale S P A L Procedimento per la preparazione di naftochinoni trans2,3-disostituiti
ES2517366T3 (es) 2009-08-20 2014-11-03 Ipca Laboratories Limited Nuevo complejo para el tratamiento y/o profilaxis de infecciones parasitarias
US20180055835A1 (en) 2016-08-25 2018-03-01 Immune Therapeutics Inc. Method for Treating And Preventing Protozoal Infections

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2533648A (en) * 1949-03-05 1950-12-12 Joseph H Warburg Circular saw making
NL6411993A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1963-10-18 1965-04-20
US3347830A (en) * 1964-07-30 1967-10-17 Grace W R & Co Process of polymerizing formaldehyde
GB1141735A (en) * 1966-11-23 1969-01-29 Pfizer & Co C Pharmaceutical anti-tumor composition
NL6817526A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1968-01-24 1969-07-28
US3655699A (en) * 1970-03-02 1972-04-11 Pfizer Analogues of lapachol as antitumor agents
DE2601458A1 (de) * 1975-01-20 1976-07-22 Ciba Geigy Ag Loesliche, von phenylindandiaminen abgeleitete polyamide
EG14152A (en) * 1977-11-22 1983-12-31 Wellcome Found Antitheilerial naphtoquinone derivatives
US4485116A (en) * 1981-10-16 1984-11-27 Hudson Alan T Antiprotozoal compounds
US4485117A (en) * 1981-10-16 1984-11-27 Hudson Alan T Antiprotozoal compounds
GB8310140D0 (en) * 1983-04-14 1983-05-18 Wellcome Found Antiprotozoal agents
US5053432A (en) * 1983-04-14 1991-10-01 Burroughs Wellcome Co. Naphthoquinone derivatives
GB8310141D0 (en) * 1983-04-14 1983-05-18 Wellcome Found Naphthoquinone derivatives
JPS59196467A (ja) * 1983-04-23 1984-11-07 Nissan Motor Co Ltd 車輪速及びまたは車輪加減速度検出方法
GB8819477D0 (en) * 1988-08-16 1988-09-21 Wellcome Found Medicaments
US5225184A (en) * 1988-08-16 1993-07-06 Burroughs Wellcome Co. Medicaments
IE65715B1 (en) * 1988-08-16 1995-11-15 Wellcome Found Medicaments
US5206268A (en) * 1988-08-16 1993-04-27 Burroughs Wellcome Co. Medicaments
GB8921516D0 (en) * 1989-09-22 1989-11-08 Wellcome Found Medicaments
GB8923254D0 (en) * 1989-10-16 1989-12-06 Wellcome Found Medicaments
US5014737A (en) * 1989-11-13 1991-05-14 Allan Berman Quartz integrated trough/sump recirculating filtered high-purity chemical bath
GB9121316D0 (en) * 1991-10-09 1991-11-20 Wellcome Found Heterocyclic compounds
GB9224739D0 (en) * 1992-11-26 1993-01-13 Wellcome Found Medicaments
GB9226905D0 (en) * 1992-12-24 1993-02-17 Wellcome Found Pharmaceutical preparation
RU2121838C1 (ru) * 1993-05-05 1998-11-20 Пало Альто Медикал Фаундейшн Способ снижения тяжести токсоплазмоза, фармацевтическая композиция, применение производных рифамицина для получения лекарственных препаратов для лечения токсоплазмоза
US5529994A (en) * 1993-05-05 1996-06-25 Palo Alto Medical Foundation Treatment for toxoplasmosis
US5733932A (en) * 1995-01-06 1998-03-31 The Picower Institute For Medical Research Compounds and methods of use to derivatize neighboring lysine residues in proteins under physiological conditions
US5744168A (en) * 1995-12-07 1998-04-28 The Procter & Gamble Company Methods and compositions for the prevention and treatment of gastrointestinal disorders
US5827543A (en) * 1995-12-07 1998-10-27 The Procter & Gamble Company Methods and compositions for the prevention and treatment of urogenital disorders
US5747476A (en) * 1996-07-17 1998-05-05 Mortar & Pestle Veterinary Pharmacy, Inc. Treatment of equine protozoal myeloencephalitis
ZA983331B (en) * 1997-05-01 1998-10-27 Allegheny University Of The He Method for treating protozoal infections
AUPO821097A0 (en) * 1997-07-25 1997-08-14 Cultor Ltd. A prophylactic
DE19737463A1 (de) * 1997-08-28 1999-03-04 Hoechst Marion Roussel De Gmbh Verwendung von Inhibitoren des Natrium-Wasserstoff-Austauschers zur Herstellung eines Arzneimittels zur Behandlung von Erkrankungen, die durch Protozoen verursacht werden
MXPA01010125A (es) * 1999-04-09 2002-06-04 Glaxo Group Ltd Combinacion de una preparacion para el tratamiento de la malaria.

Also Published As

Publication number Publication date
UA45948C2 (uk) 2002-05-15
CY2193B1 (en) 2002-11-08
MY114241A (en) 2002-09-30
CN1087935C (zh) 2002-07-24
HU9501537D0 (en) 1995-07-28
WO1994012164A1 (en) 1994-06-09
US6291488B1 (en) 2001-09-18
CZ119295A3 (en) 1995-11-15
SK281559B6 (sk) 2001-05-10
NO951995D0 (no) 1995-05-19
EP0670719A1 (en) 1995-09-13
NO951995L (no) 1995-07-03
AP517A (en) 1996-08-23
CA2150234E (en) 2005-03-22
RO119280B1 (ro) 2004-07-30
BG62595B1 (bg) 2000-03-31
ATE191340T1 (de) 2000-04-15
CN1091632A (zh) 1994-09-07
IL107755A0 (en) 1994-02-27
AU5532294A (en) 1994-06-22
NZ257901A (en) 1997-01-29
EP0670719B1 (en) 2000-04-05
PL174323B1 (pl) 1998-07-31
SK57095A3 (en) 1996-05-08
GB9224739D0 (en) 1993-01-13
AU685408B2 (en) 1998-01-22
US5998449A (en) 1999-12-07
CA2150234C (en) 2001-01-16
IL107755A (en) 2000-10-31
PE55694A1 (es) 1995-01-25
SI9300614A (en) 1994-06-30
OA10352A (en) 2001-10-22
SG45387A1 (en) 1998-01-16
MX9307402A (es) 1994-07-29
HK1004468A1 (en) 1998-11-27
CA2150234A1 (en) 1994-06-09
GR3033745T3 (en) 2000-10-31
AP9300592A0 (en) 1994-01-31
ZA938832B (en) 1995-05-25
ES2145114T3 (es) 2000-07-01
US6166046A (en) 2000-12-26
SA93140434B1 (ar) 2004-09-01
BG99656A (bg) 1996-04-30
PT670719E (pt) 2000-09-29
DE69328307T2 (de) 2000-10-26
RU2108092C1 (ru) 1998-04-10
KR100294802B1 (ko) 2001-09-17
DE69328307D1 (de) 2000-05-11
CZ289171B6 (cs) 2001-11-14
HUT71346A (en) 1995-11-28
JPH08503938A (ja) 1996-04-30
NO313225B1 (no) 2002-09-02
HU225918B1 (en) 2007-12-28
CZ289692B6 (cs) 2002-03-13
JP3768231B2 (ja) 2006-04-19
PL309222A1 (en) 1995-10-02
DK0670719T3 (da) 2000-07-31

Similar Documents

Publication Publication Date Title
DK0634000T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
TW278290B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
TW229241B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IN187357B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
TW218417B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK145092D0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
TW240197B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK41992D0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IN185983B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK148492D0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP0731033A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK0648175T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR2690133B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
TW234716B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
TW252113B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU632452B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
TW270923B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
TW210775U (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK146492D0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IN180807B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IN173710B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IN177777B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IN178951B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IN180537B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IN185270B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Legal Events

Date Code Title Description
MK4A Expiration of patent term of an invention patent